VivoSeq
Other

Smoking Reduction

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Smoking Reduction is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed6 · 100%

Clinical Trials

Trial Activity

6 trials

Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong
Completed·—·Phase 4·NCT03879889·210 enrolled
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
Completed·UUniversity of Texas at Austin·Phase 1·NCT01944423·53 enrolled
Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?
Completed·SShaare Zedek Medical Center·Phase 4·NCT02634281·242 enrolled
N-Acetylcysteine and Smoking Reduction
Completed·MMedical University of South Carolina·Phase 2·NCT00751257·33 enrolled
Smoking Reduction or Cessation With Nicotine Replacement Therapy
Completed·MMcNeil AB·Phase 3·NCT00840242·314 enrolled
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Completed·RRose Research Center, LLC·Phase 3·NCT06554873·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)